Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models. Tomita Y, Link G, Ge Y, Gold ERH, et al. PLoS One 2025;20:e0323235.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tomita Y, Link G, Ge Y, Gold ERH, et al. Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models. PLoS One 2025;20:e0323235.
PMID: 41428766